KENNETH B JR LEE

CIK 1208570 · last filed 2023-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$599.1K

Companies

8

Total Filings

62

Lifetime Open-Market Net

$5.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCRX Director 68,863 $8.70 $599.1K -$245.6K 16 2023-06-15
HYPERION DEFI, INC. (EYEN) Delisted Director 64,544 $15.82 $1.02M $54.5K 7 2022-06-21
Aralez Pharmaceuticals Inc. (ARLZ) Delisted Director 102,952 $21.1K 7 2017-05-12
Clearside Biomedical, Inc. (CLSD) Delisted 10%+ Owner 1,675,878 $0.35 $589.2K $6.00M 1 2016-06-07
POZEN INC /NC (POZN) Delisted Director 97,495 -$96.5K 12 2015-06-25
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted Director 0 $7.8K 7 2011-05-16
OSI PHARMACEUTICALS INC (OSIP) Delisted Director 0 $0 4 2010-06-07
CV THERAPEUTICS INC (CVTX) Delisted Director 24,265 $0 4 2009-04-16

Recent Filings · Page 2 of 7

62 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-14 BCRX Grant (A) $0 EDGAR
2019-11-18 BCRX Buy (P) +5,000 $7.2K EDGAR
2019-08-20 HYPERION DEFI, INC. (EYEN) Delisted Grant (A) +8,038 $0 EDGAR
2019-05-31 BCRX Grant (A) $0 EDGAR
2018-07-26 HYPERION DEFI, INC. (EYEN) Delisted Grant (A) +4,033 $0 EDGAR
2018-06-22 BCRX Grant (A) $0 EDGAR
2017-05-25 BCRX Grant (A) $0 EDGAR
2017-05-12 Aralez Pharmaceuticals Inc. (ARLZ) Delisted Grant (A) +7,500 $0 EDGAR
2017-03-17 Aralez Pharmaceuticals Inc. (ARLZ) Delisted Buy (P) +5,000 $12.6K EDGAR
2016-11-15 Aralez Pharmaceuticals Inc. (ARLZ) Delisted Buy (P) +1,000 $5.0K EDGAR
Showing 1120 of 62
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.